Andrew Dudum, cofounder of San Francisco-based online pharmacy Hims & Hers, a seller of wellness products for men and women – including hair loss and erectile dysfunction pills – is now a billionaire ...

The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency cited ...

The Food and Drug Administration (FDA) issued a public warning about compounded topical versions of a popular hair loss drug sold through telehealth platforms. However, the agency has not approved any ...

Hims & Hers Health, Inc. (HIMS) presents a compelling risk-reward profile as bearish sentiment and regulatory concerns appear fully priced into the stock. HIMS is aggressively expanding its product ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." I'M NOT HERE to scare you, but if you’re reading this, you’re probably going to experience hair loss at ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Hair loss might not sound like a ...

Telehealth storefront Hims & Hers Health has been a fast-growing company with a pricey stock. A disappointing sales figure in its latest quarter has caught investors by surprise. Hims shares opened ...

The Food and Drug Administration building is seen on Dec. 10, 2020, in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) WASHINGTON (AP) — For the first time, federal health officials are taking ...

Now, the U.S. Food and Drug Administration (FDA) is warning the public about the risks. (HealthDay News) — A quick spray of medication might seem like an easy way to get thicker hair, but some people ...

WASHINGTON (AP) — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — ...